David Marais

1.3k total citations
16 papers, 534 citations indexed

About

David Marais is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David Marais has authored 16 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in David Marais's work include Lipoproteins and Cardiovascular Health (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Lipid metabolism and disorders (5 papers). David Marais is often cited by papers focused on Lipoproteins and Cardiovascular Health (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Lipid metabolism and disorders (5 papers). David Marais collaborates with scholars based in South Africa, Canada and United States. David Marais's co-authors include Pauline de la Μ. Hall, Richard Kirsch, Enid Shephard, Mohamed Jaffer, Ralph E. Kirsch, Michael R. Hayden, Howard Henderson, Stéphane Canaan, Lutz Thilo and Wladimir Malaga and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and The American Journal of Human Genetics.

In The Last Decade

David Marais

16 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Marais South Africa 11 249 165 155 129 87 16 534
Liangsu Wang United States 14 258 1.0× 156 0.9× 241 1.6× 234 1.8× 63 0.7× 25 731
Waqar Khalid Saeed South Korea 13 300 1.2× 104 0.6× 103 0.7× 190 1.5× 28 0.3× 26 554
Nadine Gehrke Germany 15 351 1.4× 111 0.7× 68 0.4× 391 3.0× 50 0.6× 22 1.0k
Eszter Trojnár United States 11 234 0.9× 52 0.3× 118 0.8× 164 1.3× 50 0.6× 16 647
Traci E. Stankiewicz United States 12 371 1.5× 68 0.4× 66 0.4× 172 1.3× 55 0.6× 22 686
Julia Perttilä Finland 15 410 1.6× 319 1.9× 191 1.2× 251 1.9× 162 1.9× 17 873
S. Galastri Italy 13 426 1.7× 92 0.6× 150 1.0× 161 1.2× 53 0.6× 17 790
Jason Behary Australia 8 316 1.3× 77 0.5× 114 0.7× 294 2.3× 25 0.3× 18 664
Kyoko Tomita Japan 16 340 1.4× 86 0.5× 97 0.6× 304 2.4× 34 0.4× 32 772

Countries citing papers authored by David Marais

Since Specialization
Citations

This map shows the geographic impact of David Marais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Marais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Marais more than expected).

Fields of papers citing papers by David Marais

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Marais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Marais. The network helps show where David Marais may publish in the future.

Co-authorship network of co-authors of David Marais

This figure shows the co-authorship network connecting the top 25 collaborators of David Marais. A scholar is included among the top collaborators of David Marais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Marais. David Marais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Cour, Martin, et al.. (2021). Chronic and moderate consumption of reduced-alcohol wine confers cardiac benefits in a rat model of pulmonary arterial hypertension. BMC Research Notes. 14(1). 324–324. 3 indexed citations
2.
Calder, Bridget, Dee Blackhurst, David Marais, et al.. (2020). Analysis of the regenerative capacity of human serum exosomes after a simple multistep separation from lipoproteins. Journal of Tissue Engineering and Regenerative Medicine. 15(1). 63–77. 10 indexed citations
3.
Pallazola, Vincent A., Vasanth Sathiyakumar, Jihwan Park, et al.. (2019). Modern prevalence of dysbetalipoproteinemia (Fredrickson-Levy-Lees type III hyperlipoproteinemia). Archives of Medical Science. 16(5). 993–1003. 23 indexed citations
4.
Miller, Sharon A., Amanda J. Hooper, David Marais, et al.. (2016). Novel APOB missense variants, A224T and V925L, in a black South African woman with marked hypocholesterolemia. Journal of clinical lipidology. 10(3). 604–609. 2 indexed citations
5.
Ross, Ian Louis, Ragnhildur Bergthorsdottir, Naomi Levitt, et al.. (2014). Cardiovascular Risk Factors in Patients with Addison's Disease: A Comparative Study of South African and Swedish Patients. PLoS ONE. 9(3). e90768–e90768. 22 indexed citations
7.
Subedi, Yagya Prasad, et al.. (2013). Dietary Shifts in Nepal and its possible impacts on overweight and obesity. Proceedings of The Nutrition Society. 72(OCE5). 1 indexed citations
8.
Marais, David, Dirk Blom, Francine Petrides, Yann Gouëffic, & Gilles Lambert. (2012). Proprotein convertase subtilisin/kexin type 9 inhibition. Current Opinion in Lipidology. 23(6). 511–517. 34 indexed citations
9.
Lamont, Kim, et al.. (2012). Lowering the alcohol content of red wine does not alter its cardioprotective properties. South African Medical Journal. 102(6). 565–565. 13 indexed citations
10.
Cromwell, William C., Raúl D. Santos, Dirk Blom, et al.. (2010). Mipomersen, a First-in-Class Apolipoprotein B Synthesis Inhibitor, Lowers Lipoprotein (a) in Patients with Homozygous Familial Hypercholesterolemia. Journal of clinical lipidology. 4(3). 221–221. 3 indexed citations
11.
Marais, David. (2003). Lipoprotein metabolism and its derangements : main topic. 21(7). 384–390. 1 indexed citations
12.
Kirsch, Richard, Enid Shephard, David Marais, et al.. (2003). Rodent nutritional model of non‐alcoholic steatohepatitis: Species, strain and sex difference studies. Journal of Gastroenterology and Hepatology. 18(11). 1272–1282. 214 indexed citations
13.
Durst, Ronen, Roberto Colombo, Shoshi Shpitzen, et al.. (2001). Recent Origin and Spread of a Common Lithuanian Mutation, G197del LDLR, Causing Familial Hypercholesterolemia: Positive Selection Is Not Always Necessary to Account for Disease Incidence among Ashkenazi Jews. The American Journal of Human Genetics. 68(5). 1172–1188. 40 indexed citations
14.
Henderson, Howard, et al.. (1998). A novel Glu421Lys substitution in the lipoprotein lipase gene in pregnancy-induced hypertriglyceridemic pancreatitis. Clinica Chimica Acta. 269(1). 1–12. 36 indexed citations
15.
Henderson, Howard, et al.. (1996). A New Mutation Destroying Disulphide Bridging in the C-Terminal Domain of Lipoprotein Lipase. Biochemical and Biophysical Research Communications. 227(1). 189–194. 28 indexed citations
16.
Meiner, Vardiella, et al.. (1994). Premature termination codon at the sterol 27-hydroxylase gene causes cerebrotendinous xanthomatosis in an Afrikaner family. Human Molecular Genetics. 3(1). 193–194. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026